JWM
PCVX icon

JPL Wealth Management’s Vaxcyte PCVX Stock Holding History

JPL Wealth Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$291 Buy
+5
New +$271 ﹤0.01% 1370
2025
Q4 		– Sell
-5
Closed -$181 – 828
2025
Q3 		$181 Buy
+5
New +$166 ﹤0.01% 1151

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JPL Wealth Management's PCVX Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Vaxcyte (PCVX) in Q1 2026: 5 shares worth $291. The stake represents ﹤0.01% of the portfolio and ranks #1370 among its holdings. This is a return to the name: JPL Wealth Management previously reported a position in PCVX as recently as Q3 2025.

JPL Wealth Management first reported a position in PCVX in Q3 2025 and has held it in 2 quarters since. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • JPL Wealth Management held 5 shares of Vaxcyte worth $291 as of Q1 2026.
  • Vaxcyte was a new JPL Wealth Management position in Q1 2026.
  • Vaxcyte made up ﹤0.01% of JPL Wealth Management's portfolio in Q1 2026, its #1370 holding.
  • JPL Wealth Management first reported a position in Vaxcyte in Q3 2025 and has held it in 2 quarters since.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.